FDAnews
www.fdanews.com/articles/192347-misonix-earns-ce-mark-for-ultrasonic-surgical-device

Misonix Earns CE Mark for Ultrasonic Surgical Device

August 13, 2019

Misonix’s Nexus platform has gained the CE Mark, following the FDA’s approval of the system in June.

The ultrasonic surgical device combines all of the company’s solutions into a single platform, including its BoneScalpel, SonicOne and Sonastar, and it is designed to accommodate future devices.

Nexus features a new digital algorithm that provides more control and efficiency, and increased power to improve tissue resection rates.

View today's stories